Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ADRENALINE VIATRIS contains the active ingredient adrenaline ...
The U.S. Food and Drug Administration (FDA) has approved Richmond-based Kaléo’s supplemental drug application for the first epinephrine auto-injector specifically for infants and children with serious ...
Research published in Clinical and Experimental Allergy journal demonstrates how NHS prescription data is helping to improve anaphylaxis management across England. Analysis of adrenaline auto-injector ...
JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...
CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...
Anaphylactic shock is the most common chronic disease in Europe and North America region. Allergy UK says, approximately 20% of patients struggle with anaphylactic reaction in Europe. Anaphylactic ...
Two new research papers show how NHS Business Services Authority (NHSBSA) prescription data is advancing clinical understanding of adrenaline auto-injector (AAI) prescribing patterns and informing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results